PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9271379-7 1997 In contrast, exposure to the alkylating agent methyl methanesulfonate results in similar increases of p53 and p21(WAF1/CIP1) mRNA in both cell types. Methyl Methanesulfonate 46-69 cyclin dependent kinase inhibitor 1A Homo sapiens 110-113 10749849-2 2000 We show that the gene encoding the gut-enriched Kruppel-like factor (GKLF, KLF4) is concurrently induced with p21(WAF1/Cip1) during serum deprivation and DNA damage elicited by methyl methanesulfonate. Methyl Methanesulfonate 177-200 cyclin dependent kinase inhibitor 1A Homo sapiens 110-113 10749849-2 2000 We show that the gene encoding the gut-enriched Kruppel-like factor (GKLF, KLF4) is concurrently induced with p21(WAF1/Cip1) during serum deprivation and DNA damage elicited by methyl methanesulfonate. Methyl Methanesulfonate 177-200 cyclin dependent kinase inhibitor 1A Homo sapiens 114-118 10749849-2 2000 We show that the gene encoding the gut-enriched Kruppel-like factor (GKLF, KLF4) is concurrently induced with p21(WAF1/Cip1) during serum deprivation and DNA damage elicited by methyl methanesulfonate. Methyl Methanesulfonate 177-200 cyclin dependent kinase inhibitor 1A Homo sapiens 119-123 10749849-4 2000 Moreover, during the first 30 min of methyl methanesulfonate treatment, the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Methyl Methanesulfonate 37-60 cyclin dependent kinase inhibitor 1A Homo sapiens 117-120 10749849-4 2000 Moreover, during the first 30 min of methyl methanesulfonate treatment, the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Methyl Methanesulfonate 37-60 cyclin dependent kinase inhibitor 1A Homo sapiens 121-125 10749849-4 2000 Moreover, during the first 30 min of methyl methanesulfonate treatment, the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Methyl Methanesulfonate 37-60 cyclin dependent kinase inhibitor 1A Homo sapiens 126-130 10749849-4 2000 Moreover, during the first 30 min of methyl methanesulfonate treatment, the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Methyl Methanesulfonate 37-60 cyclin dependent kinase inhibitor 1A Homo sapiens 190-193 10749849-4 2000 Moreover, during the first 30 min of methyl methanesulfonate treatment, the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Methyl Methanesulfonate 37-60 cyclin dependent kinase inhibitor 1A Homo sapiens 194-198 10749849-4 2000 Moreover, during the first 30 min of methyl methanesulfonate treatment, the rise in Gklf mRNA level precedes that in p21(WAF1/Cip1), suggesting that GKLF may be involved in the induction of p21(WAF1/Cip1). Methyl Methanesulfonate 37-60 cyclin dependent kinase inhibitor 1A Homo sapiens 199-203 25883782-6 2015 The utility of the approach was demonstrated by the analysis of the effects of the drug (methyl methanesulfonate, MMS) on the induction of the cyclin-dependent kinase inhibitor 1a (CDKN1A) in single human cancer cells (MCF-7), demonstrating the potential of our approach for efficient, integrated single-cell RT-qPCR for gene expression analysis. Methyl Methanesulfonate 89-112 cyclin dependent kinase inhibitor 1A Homo sapiens 143-179 25883782-6 2015 The utility of the approach was demonstrated by the analysis of the effects of the drug (methyl methanesulfonate, MMS) on the induction of the cyclin-dependent kinase inhibitor 1a (CDKN1A) in single human cancer cells (MCF-7), demonstrating the potential of our approach for efficient, integrated single-cell RT-qPCR for gene expression analysis. Methyl Methanesulfonate 89-112 cyclin dependent kinase inhibitor 1A Homo sapiens 181-187 18458079-3 2008 We have recently found that the p21-dependent checkpoint can be activated and induce a prolonged arrest if S phase cells are damaged with a base-modifying agent, such as methyl methanesulfonate (MMS) and cisplatin. Methyl Methanesulfonate 170-193 cyclin dependent kinase inhibitor 1A Homo sapiens 32-35 18458079-3 2008 We have recently found that the p21-dependent checkpoint can be activated and induce a prolonged arrest if S phase cells are damaged with a base-modifying agent, such as methyl methanesulfonate (MMS) and cisplatin. Methyl Methanesulfonate 195-198 cyclin dependent kinase inhibitor 1A Homo sapiens 32-35 11890931-6 2002 Nuclear extracts from MMS-treated HCT-116 cells had higher p21WAF1/Cip1 (p21) promoter DNA-binding activity in vitro opposed to untreated cells. Methyl Methanesulfonate 22-25 cyclin dependent kinase inhibitor 1A Homo sapiens 59-71 11890931-6 2002 Nuclear extracts from MMS-treated HCT-116 cells had higher p21WAF1/Cip1 (p21) promoter DNA-binding activity in vitro opposed to untreated cells. Methyl Methanesulfonate 22-25 cyclin dependent kinase inhibitor 1A Homo sapiens 59-62 9271379-7 1997 In contrast, exposure to the alkylating agent methyl methanesulfonate results in similar increases of p53 and p21(WAF1/CIP1) mRNA in both cell types. Methyl Methanesulfonate 46-69 cyclin dependent kinase inhibitor 1A Homo sapiens 114-118 9271379-7 1997 In contrast, exposure to the alkylating agent methyl methanesulfonate results in similar increases of p53 and p21(WAF1/CIP1) mRNA in both cell types. Methyl Methanesulfonate 46-69 cyclin dependent kinase inhibitor 1A Homo sapiens 119-123 8900110-7 1996 Cells lacking the c-abl gene also responded to ara-C and MMS with increases in p53 levels and induction of p21. Methyl Methanesulfonate 57-60 cyclin dependent kinase inhibitor 1A Homo sapiens 107-110 7478567-4 1995 In contrast, the increase in p53 protein, WAF1/CIP1(p21) and GADD45 mRNA expression following exposure to the alkylating agent methylmethane sulphonate (25 and 100 micrograms ml-1) was similar in both cell types. Methyl Methanesulfonate 127-151 cyclin dependent kinase inhibitor 1A Homo sapiens 52-55